Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acetylcholine and Nicotinic Receptors in Smoking and Schizophrenia
NCT02008292Completed
- Sponsor
- Yale University
- Start
- Sep 2013
- Primary completion
- Dec 2021
- Countries
- 1
01
Overview
Open-label, single-arm trial, sponsored by Yale University. Primary endpoints: Change in Acetylcholine Levels After Physostigmine Administration and Change in Dopamine Levels After Amphetamine Administration. Started Sep 2013; status: completed.
Beyond the preview
Go deeper on NCT02008292.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02008292.